ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40936747

Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma.

Sarıtaş AG and 8 others. J Hepatocell Carcinoma, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma. Papers, record 40936747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40936747

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma.
PubMed
Journal
J Hepatocell Carcinoma
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sarıtaş AGAhmet Gökhanhttps://orcid.org/0000-0003-2715-6390
2Yavuz BBurakhttps://orcid.org/0000-0002-5262-0346
3Aydın İİshakhttps://orcid.org/0000-0002-6366-2461
4Ağca HHarun
5Topal UUğurhttps://orcid.org/0000-0003-1305-2056
6Ballı TTuğsan
7Bisgin AAtil
8Ülkü AAbdullah
9Akçam ATAtılgan Tolga

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,127,928FGF/FGFR signaling pathway involved resistance in various cancer types.J Cancer2020https://conductscience.org/library/papers/32127928PubMed
238,318,160Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy.MedComm (2020)2024https://conductscience.org/library/papers/38318160PubMed
339,819,770Preclinical evidence that fibroblast growth factor receptor pathway inhibition by BGJ398 enhances small cell lung cancer response to chemotherapy.Anticancer Drugs2025https://conductscience.org/library/papers/39819770PubMed
431,340,094Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.N Engl J Med2019https://conductscience.org/library/papers/31340094PubMed
538,831,455Targeting FGFR for cancer therapy.J Hematol Oncol2024https://conductscience.org/library/papers/38831455PubMed
636,652,354Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.N Engl J Med2023https://conductscience.org/library/papers/36652354PubMed
739,604,328Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications.Clin Mol Hepatol2025https://conductscience.org/library/papers/39604328PubMed
824,859,797A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.Target Oncol2015https://conductscience.org/library/papers/24859797PubMed
931,217,202Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma.Clin Cancer Res2019https://conductscience.org/library/papers/31217202PubMed
1036,084,663Hepatocellular carcinoma.Lancet2022https://conductscience.org/library/papers/36084663PubMed

1 to 10 of 22

See all 22 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
FBXW755,294PubTator's text mininghttps://conductscience.org/library/genes/55294NCBI Gene
FGFR12,260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
FGFR32,261PubTator's text mininghttps://conductscience.org/library/genes/2261NCBI Gene
KIT3,815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40936747

GET https://conductscience.org/api/papers/v1/40936747/references?page=2

API referenceFor AI assistants